Sharon Mates | Founder, Chairman and CEO |
Mark Neumann | EVP and Chief Commercial Officer |
Suresh Durgam | SVP and Chief Medical Officer |
Larry Hineline | SVP of Finance and CFO |
Juan Sanchez | VP, Corporate Communications and IR |
Brian Abrahams | RBC Capital Markets |
Charles Duncan | Cantor Fitzgerald |
Andrew Tsai | Jefferies |
Jessica Fye | JPMorgan |
Rudy Li | SVB Leerink |
Umer Raffat | Evercore ISI |
Graig Suvannavejh | Goldman Sachs |
Ashwani Verma | Bank of America |
Sumant Kulkarni | Canaccord Genuity |
Ladies and gentlemen, thank you for standing by, and welcome to the Intra-Cellular Therapies Second Quarter 2021 Earnings Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers’ presentation, there will be a question-and answer session. [Operator Instructions]. We ask that you please limit yourself to one question and one follow up.